BofA raised the firm’s price target on Synovus (SNV) to $60 from $59 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat and solid update, the analyst tells investors in a research note. The firm sees a discounted valuation for the shares relative to Synovus’ growth potential.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV: